Position on the procurement of tumour material
Guidance for establishments on meeting HTA licensing requirements for the procurement of tumour samples to be used as a starting material in the manufactur...
Search results for
HFEA and HTA joint statement on ovarian and testicular tissue storage
The Human Fertilisation and Embryology Authority (HFEA) and the Human Tissue Authority (HTA) have been working together to reduce the regulatory overlap re...
Clarification of the scope of the Medical Devices Regulation for tissues and cells products
New EU regulations for medical devices (MDR) and in-vitro medical devices (IVDR) have been introduced.
Regulating human embryonic stem cell lines for human application
This is the joint position from the Human Tissue Authority (HTA), Human Fertilisation and Embryology Authority (HFEA) and Medicines and Healthcare products...
Preparation Process Dossiers guidance
It is a mandatory requirement that the processes used to prepare tissue or cells for patient treatment (human application) do not render them clinically in...
Regulation of faecal microbiota transplant
Faecal microbiota transplantation (FMT) is recognised as an emerging treatment for recurrent Clostridium difficile infections in patients where antibiotic...
Compliance resource for US Imports
Importing tissue establishments must ensure that imports from third countries meet standards of quality and safety equivalent to those in the UK.
James Paget University Hospital
Establishment page with licensing information and inspection reports
Royal Devon and Exeter Hospital
Establishment page with licensing information and inspection reports
London Bridge Hospital
Establishment page with licensing information and inspection reports